In aCML, the absence of MPN-associated driver mutations, such as JAK2, CALR, and MPL, and the presence of SETBP1 and ASXL1 mutations can provide additional support for aCML diagnosis, according to ICC guidelines [3,27]. This evidence concerns the gene MPL and myeloproliferative neoplasm.